Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: Comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A)

Japanese Journal of Clinical Oncology

Volumn 46, Issue 8, 2016, Pages 748-753

  Eba, Junko ^a   Nakamura, Kenichi ^a   Mizusawa, Junki ^a   Suzuki, Kenji ^b   Nagata, Yasushi ^c   Koike, Teruaki ^d   Hiraoka, Masahiro ^e   Watanabe, Shun ichi ^f   Ishikura, Satoshi ^g   Asamura, Hisao ^h   Fukuda, Haruhikoon ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d NIIGATA CANCER CENTER HOSPITAL   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g Koshigaya Municipal Hospital   (Japan)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lobectomy; Lung cancer; Operable; Propensity score analysis; Stereotactic body radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; TREATMENT OUTCOME; ADENOCARCINOMA; AGE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; JAPAN; KAPLAN MEIER METHOD; LUNG; LUNG NEOPLASMS; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RADIOSURGERY; SEX DIFFERENCE; STATISTICAL MODEL; X-RAY COMPUTED TOMOGRAPHY;

ADENOCARCINOMA; AGE FACTORS; AGED; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LUNG; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84991376232     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyw058     Document Type: Article

References (21)

1. "Cancer Statistics in Japan" Editorial Board. Cancer statistics in Japan 2012 Foundation for Promotion of Cancer Research, 2012.
2. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-9.
3. Hanai A, Benn T, Fujimoto I, Muir CS. Comparison of lung cancer incidence rates by histological type in high and low incidence countries, with reference to the limited role of smoking. Jpn J Cancer Res 1988;79:445-52.
4. Travis WD, Lubin J, Ries L, Devesa S. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer 1996;77:2464-70.
5. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27: 3290-6.
6. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a metaanalysis. Radiother Oncol 2010;95:32-40.
7. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8.
8. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010;28:5153-9.
9. Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012;84:1060-70.
10. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6.
11. Nagata Y, Hiraoka M, Shibata T, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 nonsmall-cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys 2015;93:989-96.
12. Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 2011;6:751-6.
13. Asamura H, Hishida T, Suzuki K, et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg 2013;146:24-30.
14. Rosenbaum PR, Donald BR. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
15. Cole SR, Hernan MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 2004;75:45-9.
16. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150-61.
17. Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010;140:377-86.
18. Varlotto J, Fakiris A, Flickinger J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013;119:2683-91.
19. Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 2013;24:1543-8.
20. Zhang B, Zhu F, Ma X, et al. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. Radiother Oncol 2014;112:250-5.
21. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015;16:630-37.